title: Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy.
abstract: Few previous reports have comprehensively screened all the anti-myocardial autoantibodies (AMCA) in relation to other clinical profiles in patients with idiopathic dilated cardiomyopathy (IDC), so the present study used both immunohistochemistry (FITC) and immunoblotting (IB) for screening patients with IDC in order to characterize the clinical significance of AMCA. Sera were collected from 100 patients with IDC and age-matched 100 healthy control subjects (CTL). For FITC, an unfixed frozen section of human myocardium was used for the standard indirect immunofluorescence; for IB, total cardiac homogenates of the same myocardium were blotted to serum at 2 sets of dilution (1:200 and 1:10,000). The positive rates of AMCA detection for each method were as follows (IDC vs CTL); 39% vs 6% for FITC, 38% vs 4% for IB (1:200), and 10% vs 0% for IB (1:10,000). Fifty-nine patients with IDC and 8 CTL were positive for AMCA by either method, and 18 patients with IDC and 2 CTL were positive for AMCA by both methods. IB-positivity at 1:200 was an independent predictor by multiple logistic regression analysis of non-sustained ventricular tachycardias as well as left ventricular end-diastolic diameter and plasma norepinephrine concentration.
authors.affiliation: Department of Medicine, Kitasato Institute Hospital, Tokyo, Japan. baba-a@kitasato.or.jp
authors.forename: A
authors.initials: A
authors.lastname: Baba
authors.forename: T
authors.initials: T
authors.lastname: Yoshikawa
authors.forename: M
authors.initials: M
authors.lastname: Chino
authors.forename: A
authors.initials: A
authors.lastname: Murayama
authors.forename: K
authors.initials: K
authors.lastname: Mitani
authors.forename: S
authors.initials: S
authors.lastname: Nakagawa
authors.forename: I
authors.initials: I
authors.lastname: Fujii
authors.forename: M
authors.initials: M
authors.lastname: Shimada
authors.forename: M
authors.initials: M
authors.lastname: Akaishi
authors.forename: S
authors.initials: S
authors.lastname: Iwanaga
authors.forename: Y
authors.initials: Y
authors.lastname: Asakura
authors.forename: K
authors.initials: K
authors.lastname: Fukuda
authors.forename: H
authors.initials: H
authors.lastname: Mitamura
authors.forename: S
authors.initials: S
authors.lastname: Ogawa
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000032:analysis*; D002311:Cardiomyopathy, Dilated / Q000209:etiology / Q000276:immunology*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D007564:Japan; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000276:immunology*; D016017:Odds Ratio; D017180:Tachycardia, Ventricular / Q000276:immunology
chemical_list: D001323:Autoantibodies